Patents by Inventor Shengyun Fang

Shengyun Fang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Inhibitors of Cancer Biomarkers and Uses Thereof
    Publication number: 20230026844
    Abstract: Provided herein is an inhibitor for decreasing cellular levels X-box-binding protein 1 variant 1 (Xv1) in a cancer cell and a method for decreasing Xv1 in a cancer cell by contacting the cancer cell with this inhibitor. Also provided is a pharmaceutical composition for treating a cancer and a method for treating a cancer by administering this composition. In addition there is provided a kit for targeting Xv1 with at least one Xv1 inhibitor, at least one pharmaceutically acceptable carrier and a means for detecting the Xv1 protein or mRNA.
    Type: Application
    Filed: December 12, 2020
    Publication date: January 26, 2023
    Applicant: University of Maryland, Baltimore
    Inventors: Shengyun FANG, Yongwang ZHONG
  • DEAZAFLAVIN COMPOUNDS AND METHODS OF USE THEREOF
    Publication number: 20100048593
    Abstract: The present invention features 5-deazaflavin compounds, pharmaceutical compositions of 5-deazaflavin compounds and methods of treating a patient suffering from cancer, the method comprising administering to a patient one or more 5-deazaflavin compounds of the invention.
    Type: Application
    Filed: February 23, 2009
    Publication date: February 25, 2010
    Applicants: Government of the US, as represented by the Secretary, Department of Health & Human Services, BioVeris Corporation
    Inventors: Allan M. Weissman, Karen H. Vousden, Jane P. Jensen, Yili Yang, Shengyun Fang, Douglas Woods, John H. Kenten, Ilia Davydov, Yassamin J. Safiran, Pankaj Oberoi
  • Deazaflavin compounds and methods of use thereof
    Patent number: 7498336
    Abstract: The present invention features 5-deazaflavin compounds, pharmaceutical compositions of 5-deazaflavin compounds and methods of treating a patient suffering from cancer, the method comprising administering to a patient one or more 5-deazaflavin compounds of the invention.
    Type: Grant
    Filed: February 12, 2004
    Date of Patent: March 3, 2009
    Assignees: The United States of America as represented by the Secretary, Department of Health and Human Services, BioVeris Corporation
    Inventors: Allan M. Weissman, Karen H. Vousden, Jane P. Jensen, Yili Yang, Shengyun Fang, Douglas Woods, John H. Kenten, Ilia Davydov, Yassamin J. Safiran, Pankaj Oberoi
  • Deazaflavin compounds and methods of use thereof
    Publication number: 20060211718
    Abstract: The present invention features 5-deazaflavin compounds, pharmaceutical compositions of 5-deazaflavin compounds and methods of treating a patient suffering from cancer, the method comprising administering to a patient one or more 5-deazaflavin compounds of the invention.
    Type: Application
    Filed: February 12, 2004
    Publication date: September 21, 2006
    Applicants: GOVERNMENT OF THE US, AS REPRESENTED BY THE SEC- RETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES, BioVERIS CORPORATION
    Inventors: Allan Weissman, Karen Vousden, Jane Jensen, Yili Yang, Shengyun Fang, Douglas Woods, John Kenten, Ilia Davydov, Yassamin Safiran, Pankaj Oberoi